Prostate-specific antigen

the prostate gland (Johnson 2009). Typically, the more Prostatic Acid Phosphatase found in a sample of semen is a sign of prostate cancer. This is important because the Acid Phosphatase Color Test was once used to determine of a male had prostate cancer. It was later replaced by Prostate Specific Antigen, aka PSA. Forensic scientists still use this test to identify semen, however. In 1938, Gutman and Gutman reported increased levels of acid phosphatase in patients with metastatic prostate cancer

Elder Care Services and Prostate Cancer The Centers for Disease Control says that prostate cancer is the most common cancer in American men (other than skin cancer). Each year a man ages, his chances of developing prostate cancer increases. The good news is that prostate cancer does not typically lead to further health problems and spreads slowly. In fact, many doctors are now recommending, especially in seniors, that the cancer is monitored (an action known as active surveillance) and not treated

isn’t said about the prostate and prostate cancer in the mainstream media, except that it affects mainly men who are 40 and older. The National Cancer Institute says it’s the second most common cancer in men in the U.S., after skin cancer. It is the second leading cause of death from cancer in men. The prostate is a gland that’s part of the male reproductive system, and it helps make the sperm mobile. Besides cancer, there are other conditions that can affect the prostate as a man ages, including

Item #1: I was surprised to learn that the ancient Greeks practiced pederasty and were not considered pedophiles. I never heard of the term pederasty, so I was unaware of the difference. Ancient Greek pederasts were adult males, usually socially prominent, who have an erotic attraction to adolescent boys. These men would take on an adolescent male pupil as a lover. Many pederasts were bisexual because many were married while in homosexual relationships with adolescent boys. These sexual relationships

Benign prostate hyperplasia (BPH) and prostate cancer share a few similarities, elevated prostate-specific antigen (PSA). Along with enlargement of prostate gland that causes urinary symptoms such as, frequent urination, hesitancy, dribbling, and frequent nighttime urination. However, they are quite different which is why more tests need to be done to confirm one or the other condition. These two diseases are also similar in the fact that they both cause an enlargement of the prostate. However with

tumorigenic transformation produce oncoviral antigens. These antigens are recognized by the immune system as “non-self” because they are present on infected cells (Saxena and Bhardwaj 2017). Neoantigens, which are MHC restricted antigens, are produced by mutations in tumor cells so they are not found on all tumors. Because neoantigens are unique to the individual, vaccines that target these antigens need to be personalized (Saxena and Bhardwaj 2017). Finally, antigens that are over expressed significantly

Introduction Prostate Cancer (PCa) is the most common cancer affecting men and the second leading cause of cancer death among American men (Qaseem, Denberg, Owens, & Shekelle, 2013). Medical professionals have been using prostate specific antigen (PSA) screenings along with digital rectal exam (DRE) for many years to screen for prostate cancer. PSA was first identified in 1966 in semen, followed by the identification of PSA in blood in 1979. The PSA test has been approved for use since 1994 to detect

Turns out that prostate cancer is more deadly for your health than you may realize. Research has indicated that prostate cancer is more likely to be observed rather than treated directly. These observations come from the University of California, San Francisco, where the concerns of overtreatment are being addressed. The research conducted at UCSF found that men with low-risk prostate cancer are undergoing active surveillance, rather than aggressive treatment, in hopes of curing the illness. This

Prostate cancer is the second most common cancer and it is the second leading cause of cancer death in American men according to the American Cancer Society(ACS) ( 2016). Older age is the strongest risk factor for the development of prostate cancer. Approximately 1 in 7 men will be diagnosed with prostate cancer during his lifetime (ACS, 2016). There are more than 2.9 million prostate cancer survivors in the United States (ACS, 2016). The risk of dying from prostate cancer is 2.9 percent, with seventy

hospital IT professional who flies propeller crafts for a hobby. During a routine medical examination his doctor found blood in his urine. A prostate specific antigen (PSA) test was done that revealed a PSA of 50u/l. His only symptoms were sluggish morning urinary flow. In December of 2015 he underwent a prostate biopsy. The prostate biopsy revealed a malignant prostate adenocarcinoma with a staging of T2a and a gleason score of 7(4+3). At the time of the biopsy his PSA measured 141u/l. The urinary bladder